Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002

被引:69
作者
Schifano, F [1 ]
Oyefeso, A [1 ]
Corkery, J [1 ]
Cobain, K [1 ]
Jambert-Gray, R [1 ]
Martinotti, G [1 ]
Ghodse, AH [1 ]
机构
[1] St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England
关键词
ecstasy; MDMA; MDA; MDEA; PMA; polydrug abuse; drug-related deaths;
D O I
10.1002/hup.528
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present study reports on all deaths related to taking ecstasy (alone, or in a polydrug combination) occurring in England and Wales in the time frame August 1996-April 2002. Data presented here are based on all information recorded in the National Programme on Substance Abuse Deaths (np-SAD) database. The np-SAD regularly receives all information on drug related deaths in addicts and non addicts from coroners. A total of 202 ecstasy-related fatalities occurred in the chosen time-frame, showing a steady increase in the number of deaths each year. The ratio male:female was 4:1 and 3 of 4 victims were younger than 29. In 17% of cases ecstasy was the sole drug implicated in death and in the remaining cases a number of other drugs (mostly alcohol, cocaine, amphetamines and opiates) have been found. According to toxicology results, MDMA accounted for 86% of cases and MDA for 13% of cases; single deaths were associated with MDEA and PMA. This is the largest sample of ecstasy related deaths so far; possible explanations are given for the observed steady increase in ecstasy-related deaths and a tentative 'rationale' for this polypharmacy combination is then proposed. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 33 条
[1]  
[Anonymous], SAFER CLUBBING GUIDA
[2]  
Aust R, 2002, PREVALENCE DRUG USE
[3]  
BAL T, 2002, DRUG ABUSE TRENDS 18
[4]   Differences between ecstasy-using and nonusing methamphetamine users [J].
Brecht, ML ;
von Mayrhauser, C .
JOURNAL OF PSYCHOACTIVE DRUGS, 2002, 34 (02) :215-223
[5]  
CORKERY JM, 2002, STAT B, V402
[6]   Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low [J].
Curran, HV ;
Travill, RA .
ADDICTION, 1997, 92 (07) :821-831
[7]  
Department of Health, 2002, STAT B
[8]  
*EMCDDA, 2002, ANN REP STAT DRUGS P
[9]   Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug [J].
Fox, HC ;
Parrott, AC ;
Turner, JJD .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (04) :273-281
[10]  
GHODSE H, 2002, 9 EUR CTR ADD STUD S